Claims for Patent: 4,432,963
✉ Email this page to a colleague
Summary for Patent: 4,432,963
| Title: | Radiographic scanning agent |
| Abstract: | A composition and method for the preparation of a technetium-99m-based scanning agent are disclosed. The scanning agent is prepared from .sup.99m Tc, in a +3, +4 and/or +5 oxidation state, and a methanehydroxydiphosphonate bone-seeking agent which carries the radionuclide to bone mineral. The methanehydroxydiphosphonate agent provides scan sharpness equivalent or superior to commercial scanning agents, and is superior for detecting myocardial infarcts, as compared with commercial scanning agents such as ethane-1-hydroxy-1,1-diphosphonate and methanediphosphonate. |
| Inventor(s): | Bevan; John A. (Cincinnati, OH) |
| Assignee: | Mallinckrodt, Inc. (St. Louis, MO) |
| Application Number: | 06/225,151 |
| Patent Claims: |
1. Water-soluble stannous methanehydroxydiphosphonate.
2. Water-soluble ferrous methanehydroxydiphosphonate. 3. Water-soluble chromous methanehydroxydiphosphonate. 4. Water-soluble titanous methanehydroxydiphosphonate. 5. The water-soluble composition of matter .sup.99m Tc-methanehydroxydiphosphonate. 6. The water-soluble composition of matter .sup.99m Tc-methanehydroxydiphosphonate-tin. 7. The water-soluble composition of matter .sup.99m Tc-methanehydroxydiphosphonate-iron. 8. The water-soluble composition of matter .sup.99m Tc-methanehydroxydiphosphonate-chromium. 9. The water-soluble composition of matter .sup.99m Tc-methanehydroxydiphosphonate-titanium. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
